Initially, only those with the highest clinical need will be prioritised to receive the medication while the NHS tests a variety of new services to care for people living with obesity. Following a consultation held in October on NHS Englands request to roll out the medication over 12 years, NICE has published its guidance on the way forward
Vlenterie R, Wood ME, Brandlistuen RE, Roeleveld N, van Gelder MM, Nordeng H
Explore the results here: Obesity as a therapeutic area presents unique challenges in long-term efficacy and patient adherence in late-stage trials
In rare cases, the cancer can spread to nearby lymph nodes or other parts of your body
Label status: In January 2025, the Ozempic label was updated to state that it is not recommended in patients with severe gastroparesis, but does not indicate that the drug itself may cause the condition